[1] Boettger MK, Weber K, Grossmann D, et al.Spinal tumor necrosis factor alpha neutralization reduces peripheral inflammation and hyperalgesia and suppresses autonomic responses in experimental arthritis: a role for spinal tumor necrosis factor alpha during induction and maintenance of peripheral inflammation[J].Arthritis Rheum, 2010, 62(5):1308-1318.
[2] Neeb L, Hellen P, Boehnke C, et al.IL-1βstimulates COX-2 dependent PGE2 synthesis and CGRP release in rat trigeminal ganglia cells[J].PLoS One, 2011, 6(3): e17360-e17369.
[3] Schürks M, Kurth T.Is migraine a predictor for identifying patients at risk of stroke?[J].Expert Rev Neurother, 2011, 11(5):615-618.
[4] 中华医学会疼痛学分会头面痛学组.中国偏头痛诊断治疗指南[J].中国疼痛医学杂志, 2011, 17(2): 65-86.
[5] Yilmaz IA, Ozge A, Erdal ME, et al.Cytokine polymorphism in patients with migraine: some suggestive clues of migraine and inflammation[J].Pain Med, 2010, 11(4):492-497.
[6] Oikari LE, Stuart S, Okolicsanyi RK, et al.Investigation of lymphotoxin α geneic variants in migraine [J].Gene, 2013, 512(2):527-531.
[7] Uzar E, Evliyaoglu O, Yucel Y, et al.Serum cytokine and pro-brain natriuretic peptide (BNP) levels in patients with migraine[J].Eur Rev Med Pharmacol Sci, 2011, 15(10):1111-1116.
[8] 罗国标, 刘晓丽, 杨丽.青藤碱对偏头痛模型大鼠蛛网膜下腔炎性细胞的影响[J].中国神经精神疾病杂志, 2014, 40(4):198-201.
[9] 何秋, 王怀良, 章新华, 等.5-HT1受体激动剂对偏头痛大鼠脑膜神经源炎症的影响[J].中风与神经疾病杂志, 2007, 24(5):520-524.
[10] Maleki N, Becerra L, Borsook D.Migraine: maladaptive brain responses to stress[J].Headache, 2012, 52(suppl 2): 102-106.
[11] 谭亮, 樊光辉.偏头痛发病机制的研究进展[J].中国临床神经外科杂志, 2012, 17(9): 571-573.
[12] Ho TW, Edvinsson L, Goadsby PJ.CGRP and its receptors provide new insights into migraine pathophysiology[J].Nat Rev Neurol, 2010, 6(10):573-582.
[13] 梁瑞燕, 曹柳英, 王文君, 等.青藤碱抗炎作用机理研究[J].广州中医药大学学报, 2007, 24(2):141-143.
[14] 吴红娟, 孙必强, 朱传湘, 等.盐酸青藤碱对家兔骨关节液IL-1β、PGE-2生成与关节组织结构的影响[J].湖南中医药大学学报, 2010, 30(9):84-86.
[15] 李蕴麟, 粟戟, 尹小军, 等.青藤碱替代激素治疗类风湿性关节炎疗效分析[J].兰州大学学报:医学版, 2013, 39(3):18-21.
[16] Tfelt-Hansen P, Hougaard A.Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine[J].Expert Opin Drug Metab Toxicol, 2013, 9(1):91-103.
[17] Mitsikostas DD, Knight YE, Lasalandra M, et al.Triptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis:a mechanism to prevent central sensitization?[J].J Headache Pain, 2011, 12(4):411-417.
[18] Napoletano F, Lionetto L, Martelletti P.Sumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity[J].Expert Opin Pharmacother, 2014, 15(3):303-305.
[19] Asadollahi S, Heidari K, Vafaee R, et al.Promethazine plus sumatriptan in the treatment of migraine:a randomized clinical trial[J].Headache, 2014, 54(1):94-108.
[20] De Corato A, Capuano A, Currò D, et al.Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy[J].Neuron Glia Biol, 2012, 7(2-4):109-116.
[21] Vause CV, Durham PL.Identification of cytokines and signaling proteins differentially regulated by sumatriptan/naproxen[J].Headache, 2012, 52(1):80-89.
[22] Goadsby PJ, Lipton RB, Ferrari MD.Migraine-current understanding and treatment[J].N Engl J Med, 2002, 346(4):257-270.
[23] Landy SH, Lobo BL.Migraine treatment throughout the lifecycle[J].Expert RevNeurother, 2005, 5(3):343-353. |